LGND

Ligand Pharmaceuticals Incorporated News Headlines

$63.7
*  
0.44
0.7%
Get LGND Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Ligand Pharmaceuticals - The Bull Case
7/7/2014 12:02:00 PM - Seeking Alpha

Ligand Pharmaceuticals: Appendix
7/3/2014 12:04:00 PM - Seeking Alpha

Glaxo's Promacta in Phase III for MDS - Analyst Blog
6/26/2014 2:30:00 PM - Zacks.com

Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog
6/25/2014 4:30:00 PM - Zacks.com

TG Therapeutics Inc. (TGTX) Has Surged To A New High After License Agreement
6/24/2014 9:51:00 AM - RTT News

Capital Allocation As Stewardship (Video)
6/19/2014 3:53:00 PM - Seeking Alpha

Glaxo's Promacta Holds Promise - Analyst Blog
6/17/2014 4:45:00 PM - Zacks.com

Ligand Pharma's LGD-6972 Positive in Phase I Study - Analyst Blog
6/17/2014 4:35:00 PM - Zacks.com

Interesting LGND Put And Call Options For November 22nd
6/17/2014 11:05:55 AM - BNK Invest

Bearish outlook for Ligand from Lemelson Capital
6/16/2014 4:44:00 PM - Seeking Alpha

Ligand Pharmaceuticals - Severe Competitive Threat To Key Royalty Program And 'Going Concern' Risk Drive 100 Percent Downside
6/16/2014 2:49:00 PM - Seeking Alpha

Ligand Says Phase 3 Study Of Eltrombopag For Pediatric CITP Meets Primary Goal
6/13/2014 9:18:00 AM - RTT News

Eltrombopag Meets Primary Endpoint In Phase 3 PETIT2 Study - Quick Facts
6/13/2014 7:41:00 AM - RTT News

Interview: Ligand Management Says Product Diversification Reduces Its Risk
6/9/2014 10:16:00 AM - Seeking Alpha

Looking For Action? S&P 1500 Most Volatile Stocks
5/20/2014 11:45:00 AM - Seeking Alpha

Ligand-AstraZeneca Collaborate - Analyst Blog
5/19/2014 6:00:00 PM - Zacks.com

Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
5/16/2014 3:29:00 AM - Seeking Alpha

Ligand Signs Research, Licensing Agreement With AstraZeneca's Unit
5/14/2014 9:05:00 AM - RTT News

Spectrum Pharma Candidate Gets Positive Data - Analyst Blog
4/24/2014 5:50:01 PM - Zacks.com

Spectrum Pharma's Trial Of Captisol-Enabled Melphalan Meets Primary Endpoint
4/23/2014 7:33:00 AM - RTT News

Milestone Payment for Ligand Pharma - Analyst Blog
3/18/2014 5:30:01 PM - Zacks.com

Ligand Pharmaceuticals: A Biotech Cash Cow
3/17/2014 9:48:00 AM - Seeking Alpha

Bright Outlook at Ligand - Analyst Blog
3/12/2014 11:30:01 AM - Zacks.com

Glaxo/Ligand Look to Expand Promacta Label - Analyst Blog
3/3/2014 7:15:01 PM - Zacks.com

Ligand Pharmaceuticals - Priced To Perfection Or More Room To Run?
2/25/2014 10:26:00 AM - Seeking Alpha